About Glaukos
Glaukos is a company based in Laguna Hills (United States) founded in 2001.. Glaukos has raised $117.57 million across 10 funding rounds from investors including Orbimed, Frazier Healthcare Partners and Meritech Capital. The company has 995 employees as of December 31, 2024. Glaukos has completed 1 acquisition, including Avedro. Glaukos operates in a competitive market with competitors including Ivantis, Myra Vision, Transcend Medical, InnFocus and AqueSys, among others.
- Headquarter Laguna Hills, United States
- Employees 995 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Glaukos Corporation
-
Annual Revenue
$383.48 M21.85as on Dec 31, 2024
-
Net Profit
$-146.37 M-8.7as on Dec 31, 2024
-
EBITDA
$-68.22 M20.42as on Dec 31, 2024
-
Total Equity Funding
$117.57 M (USD)
in 10 rounds
-
Latest Funding Round
$250 M (USD), Post-IPO
Jun 08, 2020
-
Investors
Orbimed
& 7 more
-
Employee Count
995
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Glaukos
Glaukos is a publicly listed company on the NYSE with ticker symbol GKOS in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Glaukos
Glaukos has successfully raised a total of $117.57M across 10 strategic funding rounds. The most recent funding activity was a Post-IPO round of $250 million completed in June 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Post-IPO — $250.0M
-
First Round
First Round
(01 Sep 2002)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2020 | Amount | Post-IPO - Glaukos | Valuation |
investors |
|
| Jan, 2013 | Amount | Series E - Glaukos | Valuation | Meritech | |
| Oct, 2012 | Amount | Series E - Glaukos | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Glaukos
Glaukos has secured backing from 8 investors, including venture fund investors. Prominent investors backing the company include Orbimed, Frazier Healthcare Partners and Meritech Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward US-based companies.
|
Founded Year | Domain | Location | |
|
Life science & tech focused VC firm investing in the US
|
Founded Year | Domain | Location | |
|
Healthcare sector private equity investments are managed by the firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Glaukos
Glaukos has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Avedro. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Corneal collagen cross-linking technology is developed for ophthalmic applications.
|
2007 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Glaukos
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Glaukos Comparisons
Competitors of Glaukos
Glaukos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ivantis, Myra Vision, Transcend Medical, InnFocus and AqueSys, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Implantable device to relieve intraocular pressure in open angle glaucoma
|
|
| domain | founded_year | HQ Location |
Nanotechnology-based devices for glaucoma treatment are developed.
|
|
| domain | founded_year | HQ Location |
Minimally invasive glaucoma stents are developed to enhance aqueous outflow.
|
|
| domain | founded_year | HQ Location |
Glaucoma is treated via the implantable MicroShunt device in ophthalmology.
|
|
| domain | founded_year | HQ Location |
Implantable devices for glaucoma treatment are developed by AqueSys.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Glaukos
Frequently Asked Questions about Glaukos
When was Glaukos founded?
Glaukos was founded in 2001 and raised its 1st funding round 1 year after it was founded.
Where is Glaukos located?
Glaukos is headquartered in Laguna Hills, United States. It is registered at Laguna Hills, California, United States.
Is Glaukos a funded company?
Glaukos is a funded company, having raised a total of $117.57M across 10 funding rounds to date. The company's 1st funding round was a Series E of $6M, raised on Sep 01, 2002.
How many employees does Glaukos have?
As of Dec 31, 2024, the latest employee count at Glaukos is 995.
What is the annual revenue of Glaukos?
Annual revenue of Glaukos is $383.48M as on Dec 31, 2024.
What does Glaukos do?
The company was founded in 2001 and is headquartered in Laguna Hills, United States, within the medical devices sector focused on ophthalmology. Operations center on the development of the Micro-Invasive Glaucoma Surgery (MIGS) method, including the iStent device, which is implanted during cataract surgery to reduce intraocular pressure. Additional platforms for bioerodible drug delivery targeting retinal disorders are also being advanced.
Who are the top competitors of Glaukos?
Glaukos's top competitors include Myra Vision, Avisi Technologies and Sanoculis.
Is Glaukos publicly traded?
Yes, Glaukos is publicly traded on NYSE under the ticker symbol GKOS.
How many acquisitions has Glaukos made?
Glaukos has made 1 acquisition, including Avedro.
Who are Glaukos's investors?
Glaukos has 8 investors. Key investors include Orbimed, Frazier Healthcare Partners, Meritech Capital, Domain Associates, and InterWest.
What is Glaukos's ticker symbol?
The ticker symbol of Glaukos is GKOS on NYSE.